Calumet Specialty Products Partners
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Calumet Specialty Products Partners's revenues will expand 21.0% and EPS will wither -35.4%.
The average estimate for revenue is $941.3 million. On the bottom line, the average EPS estimate is $0.64.
Last quarter, Calumet Specialty Products Partners booked revenue of $1.09 billion. GAAP reported sales were 48% higher than the prior-year quarter's $733.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.42. GAAP EPS were $1.14 for Q2 against -$0.19 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 11.8%, 490 basis points better than the prior-year quarter. Operating margin was 11.6%, 1,020 basis points better than the prior-year quarter. Net margin was 6.0%, 700 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $4.13 billion. The average EPS estimate is $3.23.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 432 members out of 460 rating the stock outperform, and 28 members rating it underperform. Among 147 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 140 give Calumet Specialty Products Partners a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Calumet Specialty Products Partners is hold, with an average price target of $23.67.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Calumet Specialty Products Partners. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.
- Add Calumet Specialty Products Partners to My Watchlist.
More from The Motley Fool
Will 2018 Be Calumet Specialty Products Partners LP's Best Year Yet?
Rising sales volumes of specialty products hint at a great 2018 campaign.
Oil Refinery Stocks Are Up 30%
Some of the smaller industry players also rose more than 75%. But is there still room to keep growing?
Calumet Specialty Products Partners Earnings Were Late, but They're Still Improving
Management failed to deliver earnings on time for the third quarter, but there are signs it's getting better.